[Debate: Preventive coronary intervention for vulnerable plaque. The interventional cardiologist's approach].
作者信息
Gómez-Lara Josep
机构信息
Departamento de Cardiología, Hospital Universitari de Bellvitge, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, España Departamento de Cardiología, Hospital Universitari de Bellvitge Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) Universitat de Barcelona, L'Hospitalet de Llobregat Barcelona España.
出版信息
REC Interv Cardiol. 2024 Oct 16;7(1):54-56. doi: 10.24875/RECIC.M24000485. eCollection 2025 Jan-Mar.
Abstract
摘要
相似文献
1
[Debate: Preventive coronary intervention for vulnerable plaque. The interventional cardiologist's approach].[辩论：易损斑块的预防性冠状动脉介入治疗。介入心脏病学家的方法]
REC Interv Cardiol. 2024 Oct 16;7(1):54-56. doi: 10.24875/RECIC.M24000485. eCollection 2025 Jan-Mar.
2
[Debate: Preventive coronary intervention for vulnerable plaque. The clinical cardiologist's approach].[辩论：易损斑块的预防性冠状动脉介入治疗。临床心脏病专家的方法]
REC Interv Cardiol. 2024 Oct 16;7(1):51-53. doi: 10.24875/RECIC.M24000486. eCollection 2025 Jan-Mar.
3
Cardiac Computed Tomography Angiography in the Evaluation of Coronary Artery Disease: An Interventional Perspective.心脏计算机断层扫描血管造影在冠状动脉疾病评估中的应用：介入视角
J Soc Cardiovasc Angiogr Interv. 2024 Mar 26;3(3Part B):101301. doi: 10.1016/j.jscai.2024.101301. eCollection 2024 Mar.
4
Cardiologist's exposure to radiation in cath lab measured with Instadosedosimeter.使用即时剂量仪测量心脏科医生在导管室的辐射暴露情况。
J Radiol Prot. 2023 Feb 17;43(1). doi: 10.1088/1361-6498/acb82b.
5
[Debate. "Orbiting" around the management of stable angina. The interventional cardiologist's perspective].[辩论。围绕稳定型心绞痛的管理“盘旋”。介入心脏病学家的观点]
REC Interv Cardiol. 2024 Apr 17;6(3):235-237. doi: 10.24875/RECIC.M24000453. eCollection 2024 Jul-Sep.
6
[Debate. Asymptomatic severe aortic stenosis: when should we intervene? The interventional cardiologist's perspective].[辩论。无症状重度主动脉瓣狭窄：我们何时应进行干预？介入心脏病学家的观点]
REC Interv Cardiol. 2023 Nov 2;6(1):43-45. doi: 10.24875/RECIC.M23000419. eCollection 2024 Jan-Mar.
7
The impact of the distance from the interventional cardiologist's home to the hospital during off hours.非工作时间介入心脏病专家的家到医院的距离所产生的影响。
Catheter Cardiovasc Interv. 2014 Nov 15;84(6):950-4. doi: 10.1002/ccd.25492. Epub 2014 Apr 16.
8
A non-interventional cardiologist's guide to coronary chronic total occlusions.非介入心脏病专家的冠状动脉慢性完全闭塞指南。
Front Cardiovasc Med. 2024 Feb 6;11:1350549. doi: 10.3389/fcvm.2024.1350549. eCollection 2024.
9
Revascularization of patients with coronary artery disease: the interventional cardiologist's perspective.冠心病患者的血运重建：介入心脏病专家的观点。
Ann Thorac Surg. 1997 Jun;63(6 Suppl):S23-7. doi: 10.1016/s0003-4975(97)00438-4.
10
Lipid-lowering therapy after coronary revascularization: the interventional cardiologist's perspective.冠状动脉血运重建术后的降脂治疗：介入心脏病学家的观点。
Am J Cardiol. 1998 Apr 9;81(7A):55E-62E. doi: 10.1016/s0002-9149(98)00199-4.
本文引用的文献
1
Paclitaxel-coated balloons for vulnerable lipid-rich plaques.用于富含脂质易损斑块的紫杉醇涂层球囊。
EuroIntervention. 2024 Jul 1;20(13):e826-e830. doi: 10.4244/EIJ-D-23-01073.
2
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.预防性经皮冠状动脉介入治疗与单纯最佳药物治疗治疗易损动脉粥样硬化性冠状动脉斑块（PREVENT）：一项多中心、开放标签、随机对照试验。
Lancet. 2024 May 4;403(10438):1753-1765. doi: 10.1016/S0140-6736(24)00413-6. Epub 2024 Apr 8.
3
Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years.6 年内亚临床动脉粥样硬化进展和消退的决定因素。
J Am Coll Cardiol. 2023 Nov 28;82(22):2069-2083. doi: 10.1016/j.jacc.2023.09.814.
4
Impact of physician's perception about LDL cholesterol control in clinical practice when treating patients in Spain.西班牙临床治疗中医生对 LDL 胆固醇控制的认知对治疗的影响。
Atherosclerosis. 2023 Jun;375:38-44. doi: 10.1016/j.atherosclerosis.2023.04.013. Epub 2023 May 11.
5
Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.依洛尤单抗联合高强度他汀治疗对急性心肌梗死患者冠状动脉粥样硬化的影响：PACMAN-AMI 随机临床试验。
JAMA. 2022 May 10;327(18):1771-1781. doi: 10.1001/jama.2022.5218.
6
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.2021年欧洲心脏病学会临床实践中心血管疾病预防指南。
Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.
7
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque.经皮冠状动脉介入治疗易损冠状动脉粥样硬化斑块
J Am Coll Cardiol. 2020 Nov 17;76(20):2289-2301. doi: 10.1016/j.jacc.2020.09.547. Epub 2020 Oct 15.
8
Long-term outcomes of chronic coronary syndrome worldwide: insights from the international CLARIFY registry.全球慢性冠状动脉综合征的长期结局：来自国际 CLARIFY 注册研究的见解。
Eur Heart J. 2020 Jan 14;41(3):347-356. doi: 10.1093/eurheartj/ehz660.
9
Impact of statins on serial coronary calcification during atheroma progression and regression.他汀类药物对动脉粥样硬化进展和消退过程中冠状动脉钙化的影响。
J Am Coll Cardiol. 2015 Apr 7;65(13):1273-1282. doi: 10.1016/j.jacc.2015.01.036.
10
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data.生物可吸收血管支架治疗可诱导新生内膜帽的形成，该内膜帽可封闭下方斑块，同时不影响管腔尺寸：这一概念基于系列光学相干断层扫描数据。
EuroIntervention. 2015 Nov;11(7):746-56. doi: 10.4244/EIJY14M10_06.
Zotero 插件